Genworth Financial (GNW) Q4 FY25 earnings call: guidance and Q&A

Earnings call· Dec 2025 (Q4 FY25)· Financials· Feb 24, 2026

Source: earnings call transcript

Executive summary

Genworth Financial Q4 FY25 — Strong Enact Performance Fuels Share Repurchases and CareScout Growth

Genworth Financial delivered strong Q4 FY25 results, largely propelled by its Enact mortgage insurance segment, which funded significant share repurchases and strategic investments in the CareScout platform. While the Closed Block experienced expected losses, particularly in LTC, the company is actively managing these liabilities through in-force actions and leveraging CareScout for long-term growth and market redefinition in aging care. The focus remains on disciplined capital allocation and advancing CareScout's integrated service and insurance offerings.

Highlights

Enact contributed $146 million to Genworth's adjusted operating income in Q4 FY25 and $558 million for FY25.
Repurchased $245 million of shares in FY25, including $94 million in Q4 FY25, reducing shares outstanding by 24% since May 2022.
CareScout Quality Network matches reached 3,255 in FY25, exceeding the updated target of 3,000.
Secured $209 million in gross incremental LTC premium approvals for FY25, with an average increase of 38%.
Holding company cash interest coverage ratio on debt service remained strong at approximately 8x.

Concerns

Closed Block reported an adjusted operating loss of $114 million in Q4 FY25 and $317 million for FY25, primarily driven by LTC.
LTC adjusted operating loss was $159 million in Q4 FY25 due to a liability remeasurement loss and unfavorable assumption updates.
Unfavorable LTC A/E of $124 million pretax in Q4 FY25 was driven by higher claims and lower terminations in capped cohorts.
GLIC's consolidated risk-based capital ratio decreased to 300% at year-end 2025 from 306% at year-end 2024.
AXA litigation appeal hearing set for July 21-23, 2026, with a decision expected 3-6 months after, introducing continued uncertainty for potential $750 million recovery.

Guidance & targets

Category	Target	Timeline	Confidence
Enact Capital Return to Genworth	$405 million high materiality	FY26	High
Share Repurchases	$175 million to $225 million high materiality	FY26	Medium
CareScout Services Matches	approximately 7,500 matches medium materiality	FY26	High
CareScout Services Revenue	at least $25 million medium materiality	FY26	Medium
CareScout Services Investment	$50 million to $55 million medium materiality	FY26	High
CareScout Insurance Incremental Investment	much lower medium materiality	FY26	High
Closed Block A/E Losses	could continue to see losses at this level medium materiality	FY26	Medium

Segment performance

Segment	Revenue	YoY	QoQ	Margin
Enact Enact delivered strong performance, significantly contributing to Genworth's adjusted operating income and capital returns. New insurance written increased, and in-force grew, supported by elevated persistency. The PMIERs sufficiency remained robust, enabling substantial capital distribution to Genworth. Adjusted operating income to Genworth (FY25): $558 millionNew insurance written (Q4 FY25): $14 billionPrimary insurance in-force (YE25): $273 billionEarned premiums (Q4 FY25): $245 millionLoss ratio (Q4 FY25): 7%Net favorable reserve release (Q4 FY25): $60 million pretaxPMIERs sufficiency ratio (YE25): 162%PMIERs excess capital (YE25): $1.9 billionProceeds to Genworth (Q4 FY25): $127 millionProceeds to Genworth (FY25): $407 millionGenworth's share of Enact's book value (YE25): $4.4 billionGenworth's share of Enact's book value (YE24): $4.1 billion	—	—	—	$146 million (Q4 FY25 adjusted operating income)
Closed Block The Closed Block experienced an adjusted operating loss, primarily driven by the LTC business due to liability remeasurement and unfavorable assumption updates. Life and Annuities showed some favorable impacts from assumption updates. The segment was resegmented in Q4 FY25 to reflect the cessation of new LTC sales in GLIC and its management as a closed system. Adjusted operating loss (FY25): ($317 million)LTC adjusted operating loss (Q4 FY25): ($159 million)LTC adjusted operating loss (FY25): ($326 million)Life adjusted operating income (Q4 FY25): $13 millionLife adjusted operating loss (FY25): ($66 million)Annuities adjusted operating income (Q4 FY25): $32 millionAnnuities adjusted operating income (FY25): $75 millionLTC unfavorable A/E (Q4 FY25): ($124 million) pretaxLTC assumption updates impact (Q4 FY25): ($47 million) pretax unfavorableLife assumption updates impact (Q4 FY25): $15 million pretax favorableAnnuity assumption updates impact (Q4 FY25): $25 million pretax favorableAverage quarterly A/E losses (FY25): $75 millionGLIC consolidated RBC ratio (YE25): 300%GLIC consolidated RBC ratio (YE24): 306%GLIC capital and surplus (YE25): $3.6 billionGLIC cash flow testing margin (YE25): $0.5 billion to $1 billion	—	—	—	($114 million) (Q4 FY25 adjusted operating loss)
Corporate and Other Corporate and Other reported losses reflecting continued investment in CareScout and ongoing holding company debt service, partially offset by favorable tax items. Adjusted operating loss (FY25): ($97 million)	—	—	—	($24 million) (Q4 FY25 adjusted operating loss)

GNW operating KPIs by quarter

GNW operating KPIs stated on its earnings calls, by fiscal quarter
KPI	This call Dec 2025 Q4 FY25	Mar 2026 Q1 FY26	Jun 2026 Q2 FY26	Change vs prior quarter
CareScout matches CareScout Services	925 The team executed well in the fourth quarter, facilitating 925 matches between LTC policyholders and home care providers in our network. Source: earnings call transcript	~1,500 We facilitated approximately 1,500 matches between care seekers and providers in the first quarter reflecting strong sequential and year-over-year growth. Source: earnings call transcript	~1,450 We facilitated approximately 1,450 matches between care seekers and providers in the second quarter, bringing total matches for the first half of the year to approximately 2,950, over double the number of matches achieved in the first half of 2025. Source: earnings call transcript	—
New insurance written Enact	$14B New insurance written of $14 billion in the quarter increased versus the prior quarter and prior year. Source: earnings call transcript	$13B New insurance written of $13 billion in the quarter decreased versus the prior quarter, primarily based on seasonal trends but increased versus the prior year as a result of lower interest rates early in the quarter. Source: earnings call transcript	$15B New insurance written of $15 billion in the quarter was seasonally higher than the prior quarter, an increase versus the prior year as a result of a larger estimated market size. Source: earnings call transcript	+15.4%
Primary insurance in-force Enact	$273B Primary insurance in-force grew slightly year-over-year to $273 billion, supported by both the growth in new insurance written and continued elevated persistency. Source: earnings call transcript	$272B Primary insurance in force increased year-over-year to $272 billion supported by the growth in new insurance written and continued elevated persistency. Source: earnings call transcript	$274B Primary insurance in force increased 2% year-over-year to $274 billion, supported by new insurance written and continued elevated persistency. Source: earnings call transcript	+0.7%
PMIERs sufficiency ratio Enact	162% Enact's estimated PMIERs sufficiency ratio remained strong at 162% or approximately $1.9 billion above requirements. Source: earnings call transcript	162% In Act estimated PMIERs sufficiency ratio remained strong at 162% or approximately $1.9 billion above requirements. Source: earnings call transcript	161% Enact's estimated PMIERs sufficiency ratio remained strong at 161% or approximately $1.9 billion above requirements. Source: earnings call transcript	-1 pt

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

Product	Type	Timeline	Details
Care Assurance	launch	Q4 FY25

Deals & partnerships

Seniorly Acquisition of a leading platform with a large network of senior living communities that helps families with care planning and placement. $15 million

The acquisition of Seniorly was closed in the fourth quarter. Integration is progressing well, and credentialing of major national senior living providers is underway, expected to be complete by the end of 2026.

Risks & headwinds

AXA Litigation Appeal Appeal hearing July 21-23, 2026; decision expected 3-6 months after.

Potential recovery of approximately $750 million, subject to exchange rates, if ruling is upheld. No taxes expected on recovery.

Mitigation:Recoveries are not factored into capital allocation plans but would be deployed in line with priorities: investing in CareScout, returning capital to shareholders, and reducing debt.

Closed Block LTC Liability Remeasurement and Assumption Updates Ongoing, with potential for seasonal variations in FY26.

Adjusted operating loss of $159 million in Q4 FY25, including $124 million pretax unfavorable A/E and $47 million pretax unfavorable assumption updates. FY25 average A/E losses of $75 million per quarter, potentially continuing in FY26.

Mitigation:Proactive management through multiyear rate action plan (MYRAP), benefit reductions, CareScout Quality Network, and Live Well | Age Well intervention program. Commitment to manage GLIC as a closed system without injecting new capital.

GLIC RBC Ratio Decline

Consolidated risk-based capital ratio decreased to 300% at YE25 from 306% at YE24.

Mitigation:Primarily due to higher required capital from growing limited partnership portfolio, partially offset by statutory earnings. Management aims to maintain capital discipline and self-sustainability.

What to watch in Q1 FY26

AXA Litigation Appeal Outcome

3-6 months after July 2026 hearing

Current Appeal hearing scheduled for July 21-23, 2026

Target Court of Appeal decision

Why it matters

The outcome will determine the potential recovery of approximately $750 million, impacting capital allocation flexibility.

The hearing on the appeal has now been set for July 21 through 23 of this year, and we expect the Court of Appeal to reach a decision within approximately 3 to 6 months of the hearing. If the ruling is upheld, we expect our total recoveries to be approximately $750 million, subject to exchange rates at the time.

Find out whether GNW delivers this. Inve re-checks your case every morning.

Q&A highlights

Why is it important to offer both services and insurance under the CareScout umbrella and invest in both simultaneously?

Tom McInerney explained that the LTC market is fragmented and expensive. CareScout Services provides advice, assessments, care plans, and access to a cost-efficient network (20% discounts) for the 70 million baby boomers who largely lack LTC insurance. CareScout Insurance targets the children and grandchildren of these boomers, who, after experiencing the difficulties and high costs of navigating care for their parents, will be interested in funding products for their own future needs. Samir Shah added that Genworth's 40 years of experience in supporting aging consumers gives them a unique perspective to help families across both aspects of their needs.

“CareScout is the only LTC competitor that can deliver the full value chain in the LTC ecosystem. First, CareScout services is focused on delivering LTC care advice, providing assessments of LTC care needs, working with families to develop care plans and providing access to the extensive and cost-efficient CareScout Quality Network.”

asked by Christine Jewell · answered by Thomas McInerney

2 min read 6 chapters

Detailed narrative

CareScout's Integrated Growth Strategy

CareScout is positioned as Genworth's long-term growth engine, aiming to redefine long-term care through an innovative, consumer-focused platform. It combines a services business, which helps families navigate care decisions and find providers, with an insurance product, Care Assurance, offering financial protection.

This integrated approach leverages technology and AI for improved customer service, underwriting, and product development, targeting both current care needs and future planning for the aging population.

CareScout Services Expansion and Seniorly Integration

CareScout Services made significant progress in 2025, expanding its Quality Network to approximately 790 home care providers across over 1,000 locations, covering 97% of the U.S. population aged 65 and older. The network facilitated 3,255 matches in FY25, exceeding targets.

The acquisition of Seniorly in Q4 FY25 for $15 million expanded CareScout's reach into the direct-to-consumer market and added senior living options, with credentialing of major providers expected by the end of 2026.

Care Assurance Product Launch and Distribution

CareScout successfully launched Care Assurance, its inaugural stand-alone LTC insurance product, in Q4 FY25, now live in 40 states with 4 more pending approval. This product reestablishes Genworth's presence in the LTC insurance market with a conservative and durable structure.

It differentiates through integrated services like access to the Quality Network and care planning. The company plans to broaden distribution channels with worksite and association group offerings later in 2026.

Closed Block Management and Resegmentation

Genworth continues to actively manage its self-sustaining Closed Block of LTC, Life, and Annuity businesses, now focused exclusively on existing policyholders. A resegmentation was completed in Q4 FY25 to better align reporting with business management, reflecting the cessation of new LTC sales in GLIC.

The company remains committed to managing these entities as a closed system, leveraging existing reserves without injecting new capital, and aims for a high-quality policyholder experience and sustainable risk management.

In-Force Rate Actions and Risk Mitigation

The multiyear rate action plan (MYRAP) continues to be a key lever for stabilizing the Closed Block, achieving $34.5 billion in net present value since 2012, including $1 billion from 2025 approvals. These actions, combined with benefit reduction options, have significantly reduced exposure to risky LTC policy features, such as 5% compound benefit inflation options (down to <36% from 57% in 2014) and lifetime benefits (down to 11%).

The CareScout Quality Network and Live Well | Age Well program are also expected to deliver claim savings and mitigate inflation risk.

Annual Assumption Reviews and Statutory Results

Genworth completed its annual assumption reviews for the Closed Block in Q4 FY25, with assumptions holding up in aggregate. The updates resulted in a net unfavorable impact of $6 million after tax to GAAP adjusted operating loss, primarily from LTC due to updated healthy life and near-term cost of care inflation assumptions, partially offset by favorable claim termination experience.

GLIC's consolidated risk-based capital ratio was 300% at year-end 2025, with capital and surplus of $3.6 billion.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.